Global Off-body Wearable Injectors Market Growth 2023-2029

February 2023 | 110 pages | ID: G90789AA06EFEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Off-body Wearable Injectors Industry Forecast” looks at past sales and reviews total world Off-body Wearable Injectors sales in 2022, providing a comprehensive analysis by region and market sector of projected Off-body Wearable Injectors sales for 2023 through 2029. With Off-body Wearable Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Off-body Wearable Injectors industry.

This Insight Report provides a comprehensive analysis of the global Off-body Wearable Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Off-body Wearable Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Off-body Wearable Injectors market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Off-body Wearable Injectors and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Off-body Wearable Injectors.

The global Off-body Wearable Injectors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Off-body Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Off-body Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Off-body Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Off-body Wearable Injectors players cover Becton, Dickinson and Company, Medtronic, Johnson & Johnson, Insulet Corporation, Unilife Corporation, Enable Injections, SteadyMed, Ypsomed Group and West Pharmaceutical Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Off-body Wearable Injectors market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Electronical Injectors
  • Mechanical Injectors
  • Others
Segmentation by application
  • Immuno-oncology
  • Diabetes
  • Cardiovascular Diseases
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Becton, Dickinson and Company
  • Medtronic
  • Johnson & Johnson
  • Insulet Corporation
  • Unilife Corporation
  • Enable Injections
  • SteadyMed
  • Ypsomed Group
  • West Pharmaceutical Services
  • Unilife
  • CeQur
  • Sensile Medical
  • Roche
  • ScPharmaceuticals
  • SteadyMed
Key Questions Addressed in this Report

What is the 10-year outlook for the global Off-body Wearable Injectors market?

What factors are driving Off-body Wearable Injectors market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Off-body Wearable Injectors market opportunities vary by end market size?

How does Off-body Wearable Injectors break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Off-body Wearable Injectors Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Off-body Wearable Injectors by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Off-body Wearable Injectors by Country/Region, 2018, 2022 & 2029
2.2 Off-body Wearable Injectors Segment by Type
  2.2.1 Electronical Injectors
  2.2.2 Mechanical Injectors
  2.2.3 Others
2.3 Off-body Wearable Injectors Sales by Type
  2.3.1 Global Off-body Wearable Injectors Sales Market Share by Type (2018-2023)
  2.3.2 Global Off-body Wearable Injectors Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Off-body Wearable Injectors Sale Price by Type (2018-2023)
2.4 Off-body Wearable Injectors Segment by Application
  2.4.1 Immuno-oncology
  2.4.2 Diabetes
  2.4.3 Cardiovascular Diseases
  2.4.4 Other
2.5 Off-body Wearable Injectors Sales by Application
  2.5.1 Global Off-body Wearable Injectors Sale Market Share by Application (2018-2023)
  2.5.2 Global Off-body Wearable Injectors Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Off-body Wearable Injectors Sale Price by Application (2018-2023)

3 GLOBAL OFF-BODY WEARABLE INJECTORS BY COMPANY

3.1 Global Off-body Wearable Injectors Breakdown Data by Company
  3.1.1 Global Off-body Wearable Injectors Annual Sales by Company (2018-2023)
  3.1.2 Global Off-body Wearable Injectors Sales Market Share by Company (2018-2023)
3.2 Global Off-body Wearable Injectors Annual Revenue by Company (2018-2023)
  3.2.1 Global Off-body Wearable Injectors Revenue by Company (2018-2023)
  3.2.2 Global Off-body Wearable Injectors Revenue Market Share by Company (2018-2023)
3.3 Global Off-body Wearable Injectors Sale Price by Company
3.4 Key Manufacturers Off-body Wearable Injectors Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Off-body Wearable Injectors Product Location Distribution
  3.4.2 Players Off-body Wearable Injectors Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR OFF-BODY WEARABLE INJECTORS BY GEOGRAPHIC REGION

4.1 World Historic Off-body Wearable Injectors Market Size by Geographic Region (2018-2023)
  4.1.1 Global Off-body Wearable Injectors Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Off-body Wearable Injectors Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Off-body Wearable Injectors Market Size by Country/Region (2018-2023)
  4.2.1 Global Off-body Wearable Injectors Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Off-body Wearable Injectors Annual Revenue by Country/Region (2018-2023)
4.3 Americas Off-body Wearable Injectors Sales Growth
4.4 APAC Off-body Wearable Injectors Sales Growth
4.5 Europe Off-body Wearable Injectors Sales Growth
4.6 Middle East & Africa Off-body Wearable Injectors Sales Growth

5 AMERICAS

5.1 Americas Off-body Wearable Injectors Sales by Country
  5.1.1 Americas Off-body Wearable Injectors Sales by Country (2018-2023)
  5.1.2 Americas Off-body Wearable Injectors Revenue by Country (2018-2023)
5.2 Americas Off-body Wearable Injectors Sales by Type
5.3 Americas Off-body Wearable Injectors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Off-body Wearable Injectors Sales by Region
  6.1.1 APAC Off-body Wearable Injectors Sales by Region (2018-2023)
  6.1.2 APAC Off-body Wearable Injectors Revenue by Region (2018-2023)
6.2 APAC Off-body Wearable Injectors Sales by Type
6.3 APAC Off-body Wearable Injectors Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Off-body Wearable Injectors by Country
  7.1.1 Europe Off-body Wearable Injectors Sales by Country (2018-2023)
  7.1.2 Europe Off-body Wearable Injectors Revenue by Country (2018-2023)
7.2 Europe Off-body Wearable Injectors Sales by Type
7.3 Europe Off-body Wearable Injectors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Off-body Wearable Injectors by Country
  8.1.1 Middle East & Africa Off-body Wearable Injectors Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Off-body Wearable Injectors Revenue by Country (2018-2023)
8.2 Middle East & Africa Off-body Wearable Injectors Sales by Type
8.3 Middle East & Africa Off-body Wearable Injectors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Off-body Wearable Injectors
10.3 Manufacturing Process Analysis of Off-body Wearable Injectors
10.4 Industry Chain Structure of Off-body Wearable Injectors

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Off-body Wearable Injectors Distributors
11.3 Off-body Wearable Injectors Customer

12 WORLD FORECAST REVIEW FOR OFF-BODY WEARABLE INJECTORS BY GEOGRAPHIC REGION

12.1 Global Off-body Wearable Injectors Market Size Forecast by Region
  12.1.1 Global Off-body Wearable Injectors Forecast by Region (2024-2029)
  12.1.2 Global Off-body Wearable Injectors Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Off-body Wearable Injectors Forecast by Type
12.7 Global Off-body Wearable Injectors Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Becton, Dickinson and Company
  13.1.1 Becton, Dickinson and Company Company Information
  13.1.2 Becton, Dickinson and Company Off-body Wearable Injectors Product Portfolios and Specifications
  13.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Becton, Dickinson and Company Main Business Overview
  13.1.5 Becton, Dickinson and Company Latest Developments
13.2 Medtronic
  13.2.1 Medtronic Company Information
  13.2.2 Medtronic Off-body Wearable Injectors Product Portfolios and Specifications
  13.2.3 Medtronic Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Medtronic Main Business Overview
  13.2.5 Medtronic Latest Developments
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Information
  13.3.2 Johnson & Johnson Off-body Wearable Injectors Product Portfolios and Specifications
  13.3.3 Johnson & Johnson Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Johnson & Johnson Main Business Overview
  13.3.5 Johnson & Johnson Latest Developments
13.4 Insulet Corporation
  13.4.1 Insulet Corporation Company Information
  13.4.2 Insulet Corporation Off-body Wearable Injectors Product Portfolios and Specifications
  13.4.3 Insulet Corporation Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Insulet Corporation Main Business Overview
  13.4.5 Insulet Corporation Latest Developments
13.5 Unilife Corporation
  13.5.1 Unilife Corporation Company Information
  13.5.2 Unilife Corporation Off-body Wearable Injectors Product Portfolios and Specifications
  13.5.3 Unilife Corporation Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Unilife Corporation Main Business Overview
  13.5.5 Unilife Corporation Latest Developments
13.6 Enable Injections
  13.6.1 Enable Injections Company Information
  13.6.2 Enable Injections Off-body Wearable Injectors Product Portfolios and Specifications
  13.6.3 Enable Injections Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Enable Injections Main Business Overview
  13.6.5 Enable Injections Latest Developments
13.7 SteadyMed
  13.7.1 SteadyMed Company Information
  13.7.2 SteadyMed Off-body Wearable Injectors Product Portfolios and Specifications
  13.7.3 SteadyMed Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 SteadyMed Main Business Overview
  13.7.5 SteadyMed Latest Developments
13.8 Ypsomed Group
  13.8.1 Ypsomed Group Company Information
  13.8.2 Ypsomed Group Off-body Wearable Injectors Product Portfolios and Specifications
  13.8.3 Ypsomed Group Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Ypsomed Group Main Business Overview
  13.8.5 Ypsomed Group Latest Developments
13.9 West Pharmaceutical Services
  13.9.1 West Pharmaceutical Services Company Information
  13.9.2 West Pharmaceutical Services Off-body Wearable Injectors Product Portfolios and Specifications
  13.9.3 West Pharmaceutical Services Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 West Pharmaceutical Services Main Business Overview
  13.9.5 West Pharmaceutical Services Latest Developments
13.10 Unilife
  13.10.1 Unilife Company Information
  13.10.2 Unilife Off-body Wearable Injectors Product Portfolios and Specifications
  13.10.3 Unilife Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Unilife Main Business Overview
  13.10.5 Unilife Latest Developments
13.11 CeQur
  13.11.1 CeQur Company Information
  13.11.2 CeQur Off-body Wearable Injectors Product Portfolios and Specifications
  13.11.3 CeQur Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 CeQur Main Business Overview
  13.11.5 CeQur Latest Developments
13.12 Sensile Medical
  13.12.1 Sensile Medical Company Information
  13.12.2 Sensile Medical Off-body Wearable Injectors Product Portfolios and Specifications
  13.12.3 Sensile Medical Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 Sensile Medical Main Business Overview
  13.12.5 Sensile Medical Latest Developments
13.13 Roche
  13.13.1 Roche Company Information
  13.13.2 Roche Off-body Wearable Injectors Product Portfolios and Specifications
  13.13.3 Roche Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Roche Main Business Overview
  13.13.5 Roche Latest Developments
13.14 ScPharmaceuticals
  13.14.1 ScPharmaceuticals Company Information
  13.14.2 ScPharmaceuticals Off-body Wearable Injectors Product Portfolios and Specifications
  13.14.3 ScPharmaceuticals Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 ScPharmaceuticals Main Business Overview
  13.14.5 ScPharmaceuticals Latest Developments
13.15 SteadyMed
  13.15.1 SteadyMed Company Information
  13.15.2 SteadyMed Off-body Wearable Injectors Product Portfolios and Specifications
  13.15.3 SteadyMed Off-body Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 SteadyMed Main Business Overview
  13.15.5 SteadyMed Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Off-body Wearable Injectors Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Off-body Wearable Injectors Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Electronical Injectors
Table 4. Major Players of Mechanical Injectors
Table 5. Major Players of Others
Table 6. Global Off-body Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 7. Global Off-body Wearable Injectors Sales Market Share by Type (2018-2023)
Table 8. Global Off-body Wearable Injectors Revenue by Type (2018-2023) & ($ million)
Table 9. Global Off-body Wearable Injectors Revenue Market Share by Type (2018-2023)
Table 10. Global Off-body Wearable Injectors Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Off-body Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 12. Global Off-body Wearable Injectors Sales Market Share by Application (2018-2023)
Table 13. Global Off-body Wearable Injectors Revenue by Application (2018-2023)
Table 14. Global Off-body Wearable Injectors Revenue Market Share by Application (2018-2023)
Table 15. Global Off-body Wearable Injectors Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Off-body Wearable Injectors Sales by Company (2018-2023) & (K Units)
Table 17. Global Off-body Wearable Injectors Sales Market Share by Company (2018-2023)
Table 18. Global Off-body Wearable Injectors Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Off-body Wearable Injectors Revenue Market Share by Company (2018-2023)
Table 20. Global Off-body Wearable Injectors Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Off-body Wearable Injectors Producing Area Distribution and Sales Area
Table 22. Players Off-body Wearable Injectors Products Offered
Table 23. Off-body Wearable Injectors Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Off-body Wearable Injectors Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Off-body Wearable Injectors Sales Market Share Geographic Region (2018-2023)
Table 28. Global Off-body Wearable Injectors Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Off-body Wearable Injectors Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Off-body Wearable Injectors Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Off-body Wearable Injectors Sales Market Share by Country/Region (2018-2023)
Table 32. Global Off-body Wearable Injectors Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Off-body Wearable Injectors Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Off-body Wearable Injectors Sales by Country (2018-2023) & (K Units)
Table 35. Americas Off-body Wearable Injectors Sales Market Share by Country (2018-2023)
Table 36. Americas Off-body Wearable Injectors Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Off-body Wearable Injectors Revenue Market Share by Country (2018-2023)
Table 38. Americas Off-body Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 39. Americas Off-body Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 40. APAC Off-body Wearable Injectors Sales by Region (2018-2023) & (K Units)
Table 41. APAC Off-body Wearable Injectors Sales Market Share by Region (2018-2023)
Table 42. APAC Off-body Wearable Injectors Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Off-body Wearable Injectors Revenue Market Share by Region (2018-2023)
Table 44. APAC Off-body Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 45. APAC Off-body Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 46. Europe Off-body Wearable Injectors Sales by Country (2018-2023) & (K Units)
Table 47. Europe Off-body Wearable Injectors Sales Market Share by Country (2018-2023)
Table 48. Europe Off-body Wearable Injectors Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Off-body Wearable Injectors Revenue Market Share by Country (2018-2023)
Table 50. Europe Off-body Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 51. Europe Off-body Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Off-body Wearable Injectors Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Off-body Wearable Injectors Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Off-body Wearable Injectors Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Off-body Wearable Injectors Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Off-body Wearable Injectors Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Off-body Wearable Injectors
Table 59. Key Market Challenges & Risks of Off-body Wearable Injectors
Table 60. Key Industry Trends of Off-body Wearable Injectors
Table 61. Off-body Wearable Injectors Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Off-body Wearable Injectors Distributors List
Table 64. Off-body Wearable Injectors Customer List
Table 65. Global Off-body Wearable Injectors Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Off-body Wearable Injectors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Off-body Wearable Injectors Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Off-body Wearable Injectors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Off-body Wearable Injectors Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Off-body Wearable Injectors Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Off-body Wearable Injectors Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Off-body Wearable Injectors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Off-body Wearable Injectors Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Off-body Wearable Injectors Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Off-body Wearable Injectors Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Off-body Wearable Injectors Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Off-body Wearable Injectors Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Off-body Wearable Injectors Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Becton, Dickinson and Company Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 80. Becton, Dickinson and Company Off-body Wearable Injectors Product Portfolios and Specifications
Table 81. Becton, Dickinson and Company Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Becton, Dickinson and Company Main Business
Table 83. Becton, Dickinson and Company Latest Developments
Table 84. Medtronic Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Off-body Wearable Injectors Product Portfolios and Specifications
Table 86. Medtronic Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89. Johnson & Johnson Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 90. Johnson & Johnson Off-body Wearable Injectors Product Portfolios and Specifications
Table 91. Johnson & Johnson Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Johnson & Johnson Main Business
Table 93. Johnson & Johnson Latest Developments
Table 94. Insulet Corporation Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 95. Insulet Corporation Off-body Wearable Injectors Product Portfolios and Specifications
Table 96. Insulet Corporation Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Insulet Corporation Main Business
Table 98. Insulet Corporation Latest Developments
Table 99. Unilife Corporation Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 100. Unilife Corporation Off-body Wearable Injectors Product Portfolios and Specifications
Table 101. Unilife Corporation Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Unilife Corporation Main Business
Table 103. Unilife Corporation Latest Developments
Table 104. Enable Injections Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 105. Enable Injections Off-body Wearable Injectors Product Portfolios and Specifications
Table 106. Enable Injections Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Enable Injections Main Business
Table 108. Enable Injections Latest Developments
Table 109. SteadyMed Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 110. SteadyMed Off-body Wearable Injectors Product Portfolios and Specifications
Table 111. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. SteadyMed Main Business
Table 113. SteadyMed Latest Developments
Table 114. Ypsomed Group Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 115. Ypsomed Group Off-body Wearable Injectors Product Portfolios and Specifications
Table 116. Ypsomed Group Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Ypsomed Group Main Business
Table 118. Ypsomed Group Latest Developments
Table 119. West Pharmaceutical Services Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 120. West Pharmaceutical Services Off-body Wearable Injectors Product Portfolios and Specifications
Table 121. West Pharmaceutical Services Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. West Pharmaceutical Services Main Business
Table 123. West Pharmaceutical Services Latest Developments
Table 124. Unilife Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 125. Unilife Off-body Wearable Injectors Product Portfolios and Specifications
Table 126. Unilife Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Unilife Main Business
Table 128. Unilife Latest Developments
Table 129. CeQur Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 130. CeQur Off-body Wearable Injectors Product Portfolios and Specifications
Table 131. CeQur Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. CeQur Main Business
Table 133. CeQur Latest Developments
Table 134. Sensile Medical Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 135. Sensile Medical Off-body Wearable Injectors Product Portfolios and Specifications
Table 136. Sensile Medical Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Sensile Medical Main Business
Table 138. Sensile Medical Latest Developments
Table 139. Roche Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 140. Roche Off-body Wearable Injectors Product Portfolios and Specifications
Table 141. Roche Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Roche Main Business
Table 143. Roche Latest Developments
Table 144. ScPharmaceuticals Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 145. ScPharmaceuticals Off-body Wearable Injectors Product Portfolios and Specifications
Table 146. ScPharmaceuticals Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. ScPharmaceuticals Main Business
Table 148. ScPharmaceuticals Latest Developments
Table 149. SteadyMed Basic Information, Off-body Wearable Injectors Manufacturing Base, Sales Area and Its Competitors
Table 150. SteadyMed Off-body Wearable Injectors Product Portfolios and Specifications
Table 151. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. SteadyMed Main Business
Table 153. SteadyMed Latest Developments

LIST OF FIGURES

Figure 1. Picture of Off-body Wearable Injectors
Figure 2. Off-body Wearable Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Off-body Wearable Injectors Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Off-body Wearable Injectors Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Off-body Wearable Injectors Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Electronical Injectors
Figure 10. Product Picture of Mechanical Injectors
Figure 11. Product Picture of Others
Figure 12. Global Off-body Wearable Injectors Sales Market Share by Type in 2022
Figure 13. Global Off-body Wearable Injectors Revenue Market Share by Type (2018-2023)
Figure 14. Off-body Wearable Injectors Consumed in Immuno-oncology
Figure 15. Global Off-body Wearable Injectors Market: Immuno-oncology (2018-2023) & (K Units)
Figure 16. Off-body Wearable Injectors Consumed in Diabetes
Figure 17. Global Off-body Wearable Injectors Market: Diabetes (2018-2023) & (K Units)
Figure 18. Off-body Wearable Injectors Consumed in Cardiovascular Diseases
Figure 19. Global Off-body Wearable Injectors Market: Cardiovascular Diseases (2018-2023) & (K Units)
Figure 20. Off-body Wearable Injectors Consumed in Other
Figure 21. Global Off-body Wearable Injectors Market: Other (2018-2023) & (K Units)
Figure 22. Global Off-body Wearable Injectors Sales Market Share by Application (2022)
Figure 23. Global Off-body Wearable Injectors Revenue Market Share by Application in 2022
Figure 24. Off-body Wearable Injectors Sales Market by Company in 2022 (K Units)
Figure 25. Global Off-body Wearable Injectors Sales Market Share by Company in 2022
Figure 26. Off-body Wearable Injectors Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Off-body Wearable Injectors Revenue Market Share by Company in 2022
Figure 28. Global Off-body Wearable Injectors Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Off-body Wearable Injectors Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Off-body Wearable Injectors Sales 2018-2023 (K Units)
Figure 31. Americas Off-body Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 32. APAC Off-body Wearable Injectors Sales 2018-2023 (K Units)
Figure 33. APAC Off-body Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 34. Europe Off-body Wearable Injectors Sales 2018-2023 (K Units)
Figure 35. Europe Off-body Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Off-body Wearable Injectors Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Off-body Wearable Injectors Revenue 2018-2023 ($ Millions)
Figure 38. Americas Off-body Wearable Injectors Sales Market Share by Country in 2022
Figure 39. Americas Off-body Wearable Injectors Revenue Market Share by Country in 2022
Figure 40. Americas Off-body Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 41. Americas Off-body Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 42. United States Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Off-body Wearable Injectors Sales Market Share by Region in 2022
Figure 47. APAC Off-body Wearable Injectors Revenue Market Share by Regions in 2022
Figure 48. APAC Off-body Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 49. APAC Off-body Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 50. China Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Off-body Wearable Injectors Sales Market Share by Country in 2022
Figure 58. Europe Off-body Wearable Injectors Revenue Market Share by Country in 2022
Figure 59. Europe Off-body Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 60. Europe Off-body Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 61. Germany Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Off-body Wearable Injectors Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Off-body Wearable Injectors Sales Market Share by Application (2018-2023)
Figure 70. Egypt Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Off-body Wearable Injectors Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Off-body Wearable Injectors in 2022
Figure 76. Manufacturing Process Analysis of Off-body Wearable Injectors
Figure 77. Industry Chain Structure of Off-body Wearable Injectors
Figure 78. Channels of Distribution
Figure 79. Global Off-body Wearable Injectors Sales Market Forecast by Region (2024-2029)
Figure 80. Global Off-body Wearable Injectors Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Off-body Wearable Injectors Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Off-body Wearable Injectors Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Off-body Wearable Injectors Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Off-body Wearable Injectors Revenue Market Share Forecast by Application (2024-2029)


More Publications